Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Jiangbo Commits Some of its Large Cash Hoard to buy Drug Distributor

publication date: Apr 18, 2011
Jiangbo Pharma said its China affiliate, Laiyang Jiangbo Pharmaceutical Co., signed a letter of intent to acquire Shandong Xinkangqi Medical Company, a wholesale drug distributor operating in Shandong Province. The price will be determined after Jiangbo completes its due diligence. In addition, Jiangbo said it expects to use more of its $136 million of cash reserves for more M&A in China’s drug distribution sector. Jiangbo is already very profitable: the company reported net income of $44 million on $106 million of revenue for the most recent 12 months. More details....

Stock Symbol: (NSDQ: JGBO)     Share this with colleagues:  


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital